[1] J.P. Arcede, R.L. Caga-Anan, C.Q. Mentuda, Y. Mammeri, Accounting for symptomatic and asymp
tomatic in a SEIR-type model of COVID-19, Math. Model. Nat. Phenom. 15 (2020) 34.
[2] L. Basnarkov, SEAIR epidemic spreading model of COVID-19, Chaos Solitons Fracta. 142 (2021)
110394.
[3] F. Brauer, C. Castillo-Chavez, Mathematical Models in Population Biology and Epidemiology,
Springer, 2012.
[4] L.E. Br¨ ummer, S. Katzenschlager, M. Gaeddert, C. Erdmann, S. Schmitz, M. Bota, M. Grilli, J.
Larmann, M.A. Weigand, N.R. Pollock, Diagnostic accuracy of rapid antigen tests in symptomatic
and asymptomatic SARS-CoV-2 infections, PLoS Med. 20 (2023) e1004108.
[5] N. Cangiotti, M. Capolli, M. Sensi, S. Sottile, A survey on Lyapunov functions for epidemic com
partmental models, Boll. Unione Mat. Ital. 17 (2024) 241–257.
[6] C. Castillo-Chavez, B. Song, Dynamical models of tuberculosis and their applications, Math.
Biosci. Eng. 1 (2004) 361–404.
[7] C. Cohen, J. Kleynhans, J. Moyes, M.L. McMorrow, F.K. Treurnicht, O. Hellferscee, A. Mathun
jwa, A. von Gottberg, N. Wolter, N.A. Martinson, Asymptomatic transmission and high community
burden of seasonal influenza in South Africa, Lancet Glob. Health 9 (2021) e863–e874.
[8] K.L. Cooke, Functional-differential equations: some models and perturbation problems, Differen
tial Equations and Dynamical Systems, Proc. Int. Symp., Univ. of Puerto Rico (1967) 27–30.
[9] M.C. G´ omez, E. Ibarg¨ uen Mondrag´on, Global stability analysis for a SEI model with nonlinear
incidence rate and asymptomatic infectious state, Appl. Math. Comput. 402 (2021) 126130.
[10] J.A.P. Heesterbeek, A brief history of R0 and a recipe for its calculation, Acta Biotheor. 50 (2002)
189–204.
[11] Z. Hu, C. Song, C. Xu, Clinical characteristics of 24 asymptomatic infections with COVID-19,
Infect. Dis. Poverty 9 (2020) 1–9.
[12] S.-B. Hsu, Y.-H. Hsieh, On the role of asymptomatic infection in transmission dynamics of infec
tious diseases, Bull. Math. Biol. 70 (2008) 134–155.
[13] S. Kadyrov, Y. Aitzhanov, Z.I. Muminov, Global stability analysis of a novel epidemic model with
separate compartments for symptomatic and asymptomatic cases, Lobachevskii J. Math. 46 (2025)
683–696.
[14] W.O. Kermack, A.G. McKendrick, G.T. Walker, A contribution to the mathematical theory of epi
demics, Proc. Roy. Soc. Lond. Ser. A 115 (1927) 700–721.
[15] W.O. Kermack, A.G. McKendrick, G.T. Walker, Contributions to the mathematical theory of epi
demics. II — The problem of endemicity, Proc. Roy. Soc. Lond. Ser. A 138 (1932) 55–83
[16] W.O. Kermack, A.G. McKendrick, G.T. Walker, Contributions to the mathematical theory of epi
demics. III — Further studies of the problem of endemicity, Proc. Roy. Soc. Lond. Ser. A 141 (1933)
94–122.
[17] S. Lamei, Dynamical behavior of a multi-group stochastic SEIR system with symptomatic and
asymptomatic individuals, J. Math. Model. 13(4) (2025) 767–786
[18] J. La Salle, S. Lefschetz, Stability by Liapunov’s Direct Method, Academic Press, 1961.
[19] T.W. Leulseged, D.G. Alemahu, I.S. Hassen, E.H. Maru, W.C. Zewde, N.W. Chamiso, K.T. Yegele,
D.S. Abebe, F.M. Abdi, E.Y. Minyelshewa, T.G. Gerbi, H.T. Hagos, Factors associated with de
velopment of symptomatic disease in Ethiopian COVID-19 patients, BMC Infect. Dis. 21 (2021)
759.
[20] Q. Li, X. Guan, P. Wu, X. Wang, L. Zhou, Y. Tong, R. Ren, K.S.M. Leung, E.H.Y. Lau, J.Y. Wong,
Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia, N. Engl.
J. Med. 382 (2020) 1199–1207.
[21] Z. Liu, T. Zhou, Analysis of global stability of an epidemic model with asymptomatic infected
persons, Adv. Contin. Discrete Models 2025 (2025) 85.
[22] J. Pan, Z. Chen, Y. He, T. Liu, X. Cheng, J. Xiao, H. Feng, Why controlling the asymptomatic
infection is important: A modelling study with stability and sensitivity analysis, Fractal Fract. 6
(2022) 197.
[23] S.Y. Park, Y.-M. Kim, S. Yi, S. Lee, B.-J. Na, C.B. Kim, J.-I. Kim, H.S. Kim, Y.B. Kim, Y. Park,
Coronavirus disease outbreak in call center, South Korea, Emerg. Infect. Dis. 26 (2020) 1666.
[24] E. Schuit, C. Vilaplana, J. Dinnes, J.J. Deeks, J. Domen, A. Lentferink, P. Olliaro, A. van den Bruel,
L. Hooft, P.M. Bossuyt, Serial self-testing using antigen rapid diagnostic tests in symptomatic and
asymptomatic SARS-CoV-2 infections, Lancet Microbe 4 (2023) e623–e633.
[25] Z. Shuai, Global stability of infectious disease models using Lyapunov functions, SIAM J. Appl.
Math. 73 (2013) 1513–1532.
[26] M.W. Tenforde, Symptom duration and risk factors for delayed return to usual health among out
patients with COVID-19 in a multistate health care systems network, MMWR Morb. Mortal. Wkly.
Rep. 69 (2020).
[27] N. van der Moeren, G. Zwart, E. Lodder, H. van Esch, J. Stohr, B.B. Oude Munnink, A.A. van
der Eijk, R. Molenkamp, S.D. Pas, M.P. Koopmans, Performance evaluation of the BD Veritor
SARS-CoV-2 antigen rapid test, Clin. Microbiol. Infect. 28 (2022) 1266–1272.
[28] J. Watmough, Role of incidence function in vaccine-induced backward bifurcation in some HIV
models, Math. Biosci. 210 (2007) 436–463.
[29] J. Watmough, Reproduction numbers and sub-threshold endemic equilibria for compartmental
models of disease transmission, Math. Biosci. 180 (2002) 29–48
[30] World Health Organization, Novel Coronavirus (2019-nCoV) Situation Report–142, WHO (2020).
[31] World Health Organization, Crude Birth Rate (births per 1000 population), WHO (2020).
[32] M. Yanes-Lane, N. Winters, F. Fregonese, M. Bastos, S. Perlman-Arrow, J.R. Campbell, D. Men
zies, Proportion of asymptomatic infection among COVID-19 positive persons and their transmis
sion potential, PLOS One 15 (2020) e0241536.
[33] P. Zhang, Q. Zhang, X. Wei, Q. Cui, Modeling and analysis of a class of epidemic models with
asymptomatic infection and transmission heterogeneity, J. Appl. Math. Comput. (2025) 1–28.
[34] C.-Q. Zhu, S.-D. Gao, Y. Xu, X.-H. Yang, F.-Q. Ye, L.-L. Ai, R.-C. Lv, B. Zhang, Y. Li, H. Lv, A
COVID-19 case report from asymptomatic contact, Infect. Dis. Poverty 9 (2020) 70
)